المؤلفون: Chaisai C; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand., Patikorn C; Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand., Thavorn K; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Lee SWH; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.; School of Medicine, Taylor's University, Selangor, Malaysia., Chaiyakunapruk N; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.; Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.; IDEAS Centre, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah, USA., Veettil SK; Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.; School of Medicine, Taylor's University, Selangor, Malaysia.; School of Pharmacy, Department of Pharmacy Practice, International Medical University, Kuala Lumpur, Malaysia.

المصدر: Addiction (Abingdon, England) [Addiction] 2024 Jul; Vol. 119 (7), pp. 1188-1202. Date of Electronic Publication: 2024 Mar 22.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis; Review

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1360-0443 (Electronic) Linking ISSN: 09652140 NLM ISO Abbreviation: Addiction Subsets: MEDLINE

مواضيع طبية MeSH: Varenicline*/therapeutic use , Varenicline*/economics , Smoking Cessation*/methods , Smoking Cessation*/economics , Cost-Benefit Analysis* , Smoking Cessation Agents*/therapeutic use , Smoking Cessation Agents*/economics , Bupropion*/therapeutic use , Bupropion*/economics, Humans ; Tobacco Use Cessation Devices/economics ; Behavior Therapy/economics ; Behavior Therapy/methods ; Adult

المؤلفون: Lesser LI; One Medical, San Francisco, California, USA (L.I.L.).

المصدر: Annals of internal medicine [Ann Intern Med] 2024 Sep; Vol. 177 (9), pp. JC106. Date of Electronic Publication: 2024 Sep 03.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Varenicline*/therapeutic use , Varenicline*/administration & dosage , Varenicline*/adverse effects , Smoking Cessation*/methods , Tobacco Use Cessation Devices* , Smoking Cessation Agents*/therapeutic use , Smoking Cessation Agents*/administration & dosage , Smoking Cessation Agents*/adverse effects, Humans ; Nicotinic Agonists/administration & dosage ; Nicotinic Agonists/therapeutic use ; Female ; Male ; Adult ; Middle Aged ; Smoking

المؤلفون: Fucito LM; Department of Psychiatry, Yale School of Medicine, New Haven, CT; Yale Cancer Center, Yale School of Medicine, New Haven, CT. Electronic address: lisa.fucito@yale.edu., Baldassarri SR; Department of Internal Medicine, Section of Pulmonary, Critical Care & Sleep Medicine, Yale University School of Medicine, New Haven, CT., Baker NL; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC., Palmer AM; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC., O'Malley SS; Department of Psychiatry, Yale School of Medicine, New Haven, CT., Carpenter MJ; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC., Krishnan-Sarin S; Department of Psychiatry, Yale School of Medicine, New Haven, CT., Gray KM; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC., Toll BA; Department of Psychiatry, Yale School of Medicine, New Haven, CT; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.

المصدر: American journal of preventive medicine [Am J Prev Med] 2024 Aug; Vol. 67 (2), pp. 296-298. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8704773 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2607 (Electronic) Linking ISSN: 07493797 NLM ISO Abbreviation: Am J Prev Med Subsets: MEDLINE

مواضيع طبية MeSH: Varenicline*/administration & dosage , Varenicline*/therapeutic use , Smoking Cessation*/methods , Electronic Nicotine Delivery Systems*, Humans ; Adult ; Male ; Female ; Smoking Cessation Agents/therapeutic use ; Smoking Cessation Agents/administration & dosage ; Middle Aged ; Nicotinic Agonists/administration & dosage ; Vaping ; Double-Blind Method

المؤلفون: Robinson LE; From the Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago IL., Didier N; From the Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago IL., Thomas R; From the Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago IL., Vena A; Emmes Company, Rockville, MD., King A; From the Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago IL.

المصدر: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2024 Jul-Aug 01; Vol. 44 (4), pp. 362-368. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-712X (Electronic) Linking ISSN: 02710749 NLM ISO Abbreviation: J Clin Psychopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Varenicline*/administration & dosage , Varenicline*/pharmacology , Smoking Cessation*/methods , Tobacco Use Cessation Devices* , Smoking Cessation Agents*/administration & dosage , Alcohol Drinking*, Humans ; Male ; Female ; Adult ; Middle Aged ; Follow-Up Studies ; Drug Therapy, Combination ; Treatment Outcome ; Nicotinic Agonists/administration & dosage ; Double-Blind Method

المؤلفون: Jackson SE; Department of Behavioural Science and Health, University College London, London, UK.; SPECTRUM Consortium, Edinburgh, UK., Brown J; Department of Behavioural Science and Health, University College London, London, UK.; SPECTRUM Consortium, Edinburgh, UK., Tattan-Birch H; Department of Behavioural Science and Health, University College London, London, UK.; SPECTRUM Consortium, Edinburgh, UK., Shahab L; Department of Behavioural Science and Health, University College London, London, UK.; SPECTRUM Consortium, Edinburgh, UK.

المصدر: Addiction (Abingdon, England) [Addiction] 2024 Jul; Vol. 119 (7), pp. 1203-1210. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1360-0443 (Electronic) Linking ISSN: 09652140 NLM ISO Abbreviation: Addiction Subsets: MEDLINE

مواضيع طبية MeSH: Varenicline*/therapeutic use , Smoking Cessation*/methods , Smoking Cessation Agents*/therapeutic use, Humans ; England/epidemiology ; Male ; Female ; Adult ; Middle Aged ; Cross-Sectional Studies ; Young Adult ; Adolescent ; Aged

المؤلفون: Tuisku A; Department of Medicine, Lapland Central Hospital, Rovaniemi, Finland., Rahkola M; Institute of Clinical Medicine, University of Oulu and Department of Internal Medicine Division Oulu University Hospital, Oulu, Finland., Nieminen P; Medical Informatics and Data Analysis Research Group, University of Oulu, Oulu, Finland., Toljamo T; Department of Medicine, Lapland Central Hospital, Rovaniemi, Finland.

المصدر: JAMA internal medicine [JAMA Intern Med] 2024 Aug 01; Vol. 184 (8), pp. 915-921.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN: 2168-6114 (Electronic) Linking ISSN: 21686106 NLM ISO Abbreviation: JAMA Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Varenicline*/therapeutic use , Smoking Cessation*/methods , Electronic Nicotine Delivery Systems*, Humans ; Female ; Middle Aged ; Male ; Adult ; Aged ; Smoking Cessation Agents/therapeutic use ; Finland ; Nicotinic Agonists/therapeutic use ; Nicotinic Agonists/administration & dosage ; Tobacco Use Cessation Devices

المؤلفون: Hersi M; Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Centre for Practice-Changing Research, 501 Smyth Road, Box 201, Ottawa, Ontario, K1H 8L6, Canada., Beck A; Knowledge Synthesis and Application Unit, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Hamel C; Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Centre for Practice-Changing Research, 501 Smyth Road, Box 201, Ottawa, Ontario, K1H 8L6, Canada., Esmaeilisaraji L; Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Centre for Practice-Changing Research, 501 Smyth Road, Box 201, Ottawa, Ontario, K1H 8L6, Canada., Pussegoda K; Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Centre for Practice-Changing Research, 501 Smyth Road, Box 201, Ottawa, Ontario, K1H 8L6, Canada., Austin B; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Ahmadzai N; Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Centre for Practice-Changing Research, 501 Smyth Road, Box 201, Ottawa, Ontario, K1H 8L6, Canada., Pratt M; Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Centre for Practice-Changing Research, 501 Smyth Road, Box 201, Ottawa, Ontario, K1H 8L6, Canada., Thuku M; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Yazdi F; Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Centre for Practice-Changing Research, 501 Smyth Road, Box 201, Ottawa, Ontario, K1H 8L6, Canada., Bennett A; Knowledge Synthesis and Application Unit, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. d.bennett@uottawa.ca., Shaver N; Knowledge Synthesis and Application Unit, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Vyas N; Knowledge Synthesis and Application Unit, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Skidmore B; Independent Information Specialist, Ottawa, ON, Canada., Hutton B; Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Centre for Practice-Changing Research, 501 Smyth Road, Box 201, Ottawa, Ontario, K1H 8L6, Canada.; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Manuel D; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Department of Otolaryngology, University of Ottawa, Ottawa, Ontario, Canada.; The Ottawa Hospital, Ottawa, Ontario, Canada.; Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario, K1G 5Z3, Canada., Morrow M; Patient Representative, British Columbia, Vancouver, Canada., Pakhale S; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; The Ottawa Hospital, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario, K1G 5Z3, Canada., Presseau J; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario, K1G 5Z3, Canada.; School of Psychology, University of Ottawa, Ottawa, Ontario, Canada., Shea BJ; Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Centre for Practice-Changing Research, 501 Smyth Road, Box 201, Ottawa, Ontario, K1H 8L6, Canada.; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Little J; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario, K1G 5Z3, Canada., Moher D; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, Ontario, K1G 5Z3, Canada., Stevens A; Knowledge Synthesis Group, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Centre for Practice-Changing Research, 501 Smyth Road, Box 201, Ottawa, Ontario, K1H 8L6, Canada.

المصدر: Systematic reviews [Syst Rev] 2024 Jul 12; Vol. 13 (1), pp. 179. Date of Electronic Publication: 2024 Jul 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101580575 Publication Model: Electronic Cited Medium: Internet ISSN: 2046-4053 (Electronic) Linking ISSN: 20464053 NLM ISO Abbreviation: Syst Rev Subsets: MEDLINE

مواضيع طبية MeSH: Smoking Cessation*/methods , Systematic Reviews as Topic* , Varenicline*/therapeutic use, Humans ; Adult ; Bupropion/therapeutic use ; Quinolizines/therapeutic use ; Alkaloids/therapeutic use ; Tobacco Use Cessation Devices ; Quality of Life ; Azocines/therapeutic use ; Smoking Cessation Agents/therapeutic use ; Quinolizidine Alkaloids

المؤلفون: Khan Z, Harris JR, Dearden L, Strait M, Treend K, Glesmann H, Carlini BH

المصدر: Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2024 Jul-Aug; Vol. 64 (4), pp. 102102. Date of Electronic Publication: 2024 Apr 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101176252 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1544-3450 (Electronic) Linking ISSN: 10865802 NLM ISO Abbreviation: J Am Pharm Assoc (2003) Subsets: MEDLINE

مواضيع طبية MeSH: Varenicline*/therapeutic use , Tobacco Use Cessation*/methods , Tobacco Use Cessation*/statistics & numerical data , Smoking Cessation Agents*/therapeutic use, Humans ; Tobacco Use Cessation Devices ; Smoking Cessation/methods ; Male ; Washington/epidemiology ; Female ; Adult ; Prevalence ; Middle Aged

المؤلفون: Rubaiya Talukder S; National Drug and Alcohol Research Centre, University of New South Wales, 22-32 King St, Randwick, New South Wales 2031, Australia. Electronic address: s.talukder@unsw.edu.au., Lappin J; National Drug and Alcohol Research Centre, University of New South Wales, 22-32 King St, Randwick, New South Wales 2031, Australia; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney 2200, Australia., Clare Boland V; National Drug and Alcohol Research Centre, University of New South Wales, 22-32 King St, Randwick, New South Wales 2031, Australia., Weaver N; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, 2308, Australia., McRobbie H; National Drug and Alcohol Research Centre, University of New South Wales, 22-32 King St, Randwick, New South Wales 2031, Australia., James Courtney R; National Drug and Alcohol Research Centre, University of New South Wales, 22-32 King St, Randwick, New South Wales 2031, Australia.

المصدر: Addictive behaviors [Addict Behav] 2024 Dec; Vol. 159, pp. 108148. Date of Electronic Publication: 2024 Aug 29.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 7603486 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6327 (Electronic) Linking ISSN: 03064603 NLM ISO Abbreviation: Addict Behav Subsets: MEDLINE

مواضيع طبية MeSH: Varenicline*/therapeutic use , Varenicline*/adverse effects , Quinolizines*/therapeutic use , Quinolizines*/adverse effects , Azocines*/therapeutic use , Azocines*/adverse effects , Alkaloids*/adverse effects , Alkaloids*/therapeutic use , Smoking Cessation*/methods , Smoking Cessation Agents*/therapeutic use , Smoking Cessation Agents*/adverse effects , Mental Disorders*/drug therapy , Mental Disorders*/epidemiology, Humans ; Male ; Female ; Middle Aged ; Adult ; Australia/epidemiology ; Quinolizidine Alkaloids

المؤلفون: Robijn AL; National Drug and Alcohol Research Centre, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia., Tran DT; National Drug and Alcohol Research Centre, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia., Cohen JM; Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Donald S; Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Cesta CE; Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Furu K; Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Parkin L; Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Pearson SA; Medicine Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia., Reutfors J; Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Zoega H; Medicine Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia.; Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Zwar N; Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland, Australia., Havard A; National Drug and Alcohol Research Centre, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia.; Medicine Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia.

المصدر: JAMA network open [JAMA Netw Open] 2024 Jun 03; Vol. 7 (6), pp. e2419245. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Smoking Cessation*/statistics & numerical data , Smoking Cessation*/methods , Smoking Cessation Agents*/therapeutic use , Varenicline*/therapeutic use , Varenicline*/adverse effects , Bupropion*/therapeutic use , Bupropion*/adverse effects , Tobacco Use Cessation Devices*/statistics & numerical data , Pregnancy Complications*/drug therapy , Pregnancy Complications*/epidemiology, Humans ; Female ; Pregnancy ; Adult ; Retrospective Studies ; New Zealand/epidemiology ; Sweden/epidemiology ; New South Wales/epidemiology ; Norway/epidemiology ; Young Adult ; Smoking/epidemiology ; Pregnancy Trimester, First